Summit Therapeutics Inc. Summit Therapeutics Inc.

Summit Therapeutics Inc.

SMMT

Rang în acțiuni #1659
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering,... Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.
Preț acțiune
$16.14
Ultima sincronizare: 2026-10-20
Capitalizare de piață
$12.87B
Schimbare (1 zi)
3.65%
Schimbare (1 an)
-13.88%
Țară
US
Tranzacționează Summit Therapeutics Inc. (SMMT)

Categorie

Healthcare
Istoricul spliturilor pentru Summit Therapeutics Inc. (SMMT)
Acțiunea Summit Therapeutics Inc. (simbol: SMMT) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune SMMT cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni SMMT.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL